SEARCH

SEARCH BY CITATION

References

  • Age-related Eye Disease Study Group (2001): A randomized, placebo-controlled clinical trial of high dose supplementation with vitamins C and E, beta carotene and zinc for age-related macular degeneration and vision loss. Arch Ophthalmol 119: 14171436.
  • Age-related Eye Disease Study Research Group (2000): Risk factors associated with age-related macular degeneration. A case-control study in the Age-related Eye Disease Study. Age-related Eye Disease Study Report No. 3. Ophthalmology 107: 22242232.
  • Allikmets R (2000a): Further evidence for an association of ABCR alleles with age-related macular degeneration. The International ABCR Screening Consortium. Am J Hum Genet 67: 487491.
  • Allikmets R (2000b): Simple and complex ABCR: genetic predisposition to retinal disease. Am J Hum Genet 67: 793799.
  • Appleyard M, Hansen AT, Jensen G et al. (1989): The Copenhagen City Heart Study. Østerbroundersøgelsen. A book of tables with data from the first examination (1976–78) and a 5-year follow-up (1981–83). The Copenhagen City Heart Study Group. Scand J Soc Med 41 (Suppl).
  • Baird PN, Guida E, Chu DT et al. (2004): The ε2 and ε4 alleles of the apolipoprotein gene are associated with age-related macular degeneration. Invest Ophthalmol Vis Sci 45: 13111315.
  • Bellows JG (1971): Light: a double-edged sword. Ann Ophthalmol 3: 687688.
  • Borger PH, Van Leeuwen R, Hulsman CAA et al. (2003): Is there a direct association between age-related eye diseases and mortality? Ophthalmology 110: 12921296.
  • Bressler NM, Munoz B, Maguire MG et al. (1995): Five-year incidence and disappearance of drusen and retinal pigment epithelial abnormalities. Waterman Study. Arch Ophthalmol 113: 301308.
  • Buch H, Nielsen NV, Vinding T et al. (2005a): The 14-year incidence, progression and visual morbidity of age-related maculopathy. The Copenhagen City Eye Study. Ophthalmology 112: 787798 .
  • Buch H, Vinding T, La Cour M et al. (2005b): Age-related maculopathy: a risk indicator for poorer survival in women. The Copenhagen City Eye Study. Ophthalmology 112: 305312.
  • Buch H, Vinding T, La Cour M & Nielsen NV (2001a): The prevalence and causes of bilateral and unilateral blindness in an elderly urban Danish population. The Copenhagen City Eye Study. Acta Ophthalmol Scand 79: 441449.
  • Buch H, Vinding T & Nielsen NV (2001b): Prevalence and causes of visual impairment according to World Health Organization and United States criteria in an aged, urban Scandinavian population: the Copenhagen City Eye Study. Ophthalmology 108: 23472357.
  • Chaine G, Hullo A, Sahel J et al. (1998): Case-control study of the risk factors for age-related macular degeneration. France-DMLA Study Group. Br J Ophthalmol 82: 9961002.
  • Cho E, Hankinson SE, Willett WC et al. (2000): Prospective study of alcohol consumption and the risk of age-related macular degeneration. Arch Ophthalmol 118: 681688.
  • Cruickshanks KJ, Klein R & Klein BE (1993): Sunlight and age-related macular degeneration. The Beaver Dam Eye Study. Arch Ophthalmol 111: 514518.
  • Cruickshanks KJ, Klein R, Klein BE & Nondahl DM (2001): Sunlight and the 5-year incidence of early age-related maculopathy. The Beaver Dam Eye Study. Arch Ophthalmol 119: 246250.
  • Evans JR (2001): Risk factors for age-related macular degeneration. Prog Retin Eye Res 20: 227253.
  • Eye Disease Case-control Study Group (1992): Risk factors for neovascular age-related macular degeneration. Arch Ophthalmol 110: 17011708.
  • Frikke-Schmidt R (2000): Context-dependent and invariant associations between APOE genotype and levels of lipoproteins and risk of ischaemic heart disease: a review. Scand J Clin Lab Invest 60: 326.
  • Frikke-Schmidt R, Nordestgaard BG, Agerholm-Larsen B et al. (2000a): Context-dependent and invariant associations between lipids, lipoproteins and apolipoproteins and apolipoprotein E genotype. J Lipid Res 41: 18121822.
  • Frikke-Schmidt R, Tybjærg-Hansen A, Steffensen R et al. (2000b): Apolipoprotein E genotype: ε32 women are protected while ε43 and ε44 men are susceptible to ischaemic heart disease. The Copenhagen City Heart Study. J Am Coll Cardiol 35: 11921199.
  • Goldberg J, Flowerdew G, Smith E et al. (1988): Factors associated with age-related macular degeneration. An analysis of data from the first National Health and Nutrition Examination Survey. Am J Epidemiol 128: 700710.
  • Gorin MB, Breitner JC, De Jong PT et al. (1999): The genetics of age-related macular degeneration. Mol Vis 5: 29.
  • Heiba IM, Elston RC, Klein BEK & Klein R (1993): Genetic aetiology of nuclear cataract: evidence for a major gene. Am J Med Genet 47: 12081214.
  • Heiba IM, Elston RC, Klein BE & Klein R (1994): Sibling correlations and segregation analysis of age-related maculopathy: the Beaver Dam Eye Study. Genet Epidemiol 11: 5167.
  • Hirvela H, Luukinen H, Laara E et al. (1996): Risk factors of age-related maculopathy in a population 70 years of age or older. Ophthalmology 103: 871877.
  • Hyman LG, Lilienfeld AM, Ferris FL III & Fine SL (1983): Senile macular degeneration: a case-control study. Am J Epidemiol 118: 213227.
  • De Jong PT, Bergen AA, Klaver CC et al. (2001): Age-related maculopathy: its genetic basis. Eye 15: 396400.
  • De Jong PT, Klaver CC, Wolfs RC et al. (1997): Familial aggregation of age-related maculopathy. Am J Ophthalmol 124: 862863.
  • Kahn HA, Leibowitz HM, Ganley JP et al. (1977): The Framingham Eye Study. II. Association of ophthalmic pathology with single variables previously measured in the Framingham Heart Study. Am J Epidemiol 106: 3341.
  • Katz ML, Parker KR, Handelman GJ et al. (1982): Effects of antioxidant nutrient deficiency on the retina and retinal pigment epithelium of albino rats: a light and electron microscopic study. Exp Eye Res 34: 339369.
  • Klaver CC, Assink JJ, Van Leeuwen R et al. (2001): Incidence and progression rates of age-related maculopathy: the Rotterdam Study. Invest Ophthalmol Vis Sci 42: 22372241.
  • Klaver CC, Kliffen M, Van Duijn CM et al. (1998a): Genetic association of apolipoprotein E with age-related macular degeneration. Am J Hum Genet 63: 200206.
  • Klaver CC, Wolfs RC, Assink JJ et al. (1998b): Genetic risk of age-related maculopathy. Population-based familial aggregation study. Arch Ophthalmol 116: 16461651.
  • Klein R, Davis MD, Magli YL et al. (1991): The Wisconsin Age-related Maculopathy Grading System. Ophthalmology 98: 11281134.
  • Klein R, Klein BE & Franke T (1993): The relationship of cardiovascular disease and its risk factors to age-related maculopathy. The Beaver Dam Eye Study. Ophthalmology 100: 406414.
  • Klein R, Klein BE & Jensen SC (1997a): The relation of cardiovascular disease and its risk factors to the 5-year incidence of age-related maculopathy: the Beaver Dam Eye Study. Ophthalmology 104: 18041812.
  • Klein R, Klein BE, Jensen SC & Cruickshanks KJ (1998b): The relationship of ocular factors to the incidence and progression of age-related maculopathy. Arch Ophthalmol 116: 506513.
  • Klein R, Klein BE, Jensen SC et al. (1999): Age-related maculopathy in a multiracial United States population: the National Health and Nutrition Examination Survey III. Ophthalmology 106: 10561065.
  • Klein R, Klein BE, Jensen SC & Meuer SM (1997b): The 5-year incidence and progression of age-related maculopathy: the Beaver Dam Eye Study. Ophthalmology 104: 721.
  • Klein R, Klein BE & Moss SE (1995): Age-related eye disease and survival. The Beaver Dam Eye Study. Arch Ophthalmol 113: 333339.
  • Klein R, Klein BE, Tomany SC & Cruickshanks KJ (2003): The association of cardiovascular disease with the longterm incidence of age-related maculopathy. Ophthalmology 110: 636643.
  • Klein R, Klein BE, Tomany SC et al. (2002a): Ten-year incidence and progression of age-related maculopathy: the Beaver Dam Eye Study. Ophthalmology 109: 17671779.
  • Klein R, Klein BE, Tomany SC & Moss SE (2002b): Ten-year incidence of age-related maculopathy and smoking and drinking: the Beaver Dam Eye Study. Am J Epidemiol 156: 589598.
  • Klein R, Klein BEK, Wang Q & Moss SE (1994): Is age-related maculopathy associated with cataracts? Arch Ophthalmol 112: 191196.
  • Klein R, Klein BE, Wong TY et al. (2002c): The association of cataract and cataract surgery with the longterm incidence of age-related maculopathy: the Beaver Dam Eye Study. Arch Ophthalmol 120: 15511558.
  • Klein ML, Schultz DW, Edwards A et al. (1998a): Age-related macular degeneration: clinical features in a large family and linkage to chromosome 1q. Arch Ophthalmol 116: 10821088.
  • Van Leeuwen R, Klaver CC, Vingerling JR et al. (2003): The risk and natural course of age-related maculopathy: follow-up at 6½ years in the Rotterdam Study. Arch Ophthalmol 121: 519526.
  • Van Leeuwen R, Klaver CC, Vingerling JR et al. (2004): Cholesterol and age-related macular degeneration: is there a link? Am J Ophthalmol 137: 750752.
  • Linn S, Carroll M, Johnson C et al. (1993): High density lipoprotein cholesterol and alcohol consumption in US white and black adults: data from NHANES II. Am J Public Health 83: 811816.
  • Maltzman BA, Mulvihill MN & Greenbaum A (1979): Senile macular degeneration and risk factors: a case-control study. Ann Ophthalmol 11: 11971201.
  • Manninen V, Elo MO, Frick H et al. (1988): Lipid alterations and decline in the incidence of coronary heart disease in the Helsinki Heart Study. JAMA 260: 641651.
  • Mares-Perlman JA, Brady WE, Klein BEK et al. (1995): Diet and nuclear lens opacities. Am J Epidemiol 141: 322334.
  • Mares-Perlman JA, Klein R, Klein BE et al. (1996): Association of zinc and antioxidant nutrients with age-related maculopathy. Arch Ophthalmol 114: 991997.
  • McCarty CA, Mukesh BN, Fu CL et al. (2001): Risk factors for age-related maculopathy: the Visual Impairment Project. Arch Ophthalmol 119: 14551462.
  • Meyers SM (1994): A twin study on age-related macular degeneration. Trans Am Ophthalmol Soc 92: 775843.
  • Mitchell P, Wang JJ, Foran S & Smith W (2002): Five-year incidence of age-related maculopathy lesions: the Blue Mountains Eye Study. Ophthalmology 109: 10921097.
  • Moss SE, Klein R, Klein BE et al. (1998): Alcohol consumption and the 5-year incidence of age-related maculopathy: the Beaver Dam Eye Study. Ophthalmology 105: 789794.
  • Rikans LE & Gonzalez LP (1990): Antioxidant protection systems of rat lung after chronic ethanol inhalation. Alcohol Clin Exp Res 14: 872877.
  • Rosenblum ER, Gavaler JS & Van Thiel DH (1989): Lipid peroxidation: a mechanism for alcohol-induced testicular injury. Free Radic Biol Med 7: 569577.
  • Rothman KJ (1990): No adjustments are needed for multiple comparisons. Epidemiology 1: 4346.
  • Schnohr P, Jensen G, Lange P et al. (2001): The Copenhagen City Heart Study. Østerbroundersøgelsen. Tables with data from the third examination 1991–94. Eur Heart J 3 (Suppl): 1−83.
  • Schnohr P, Jensen G, Nyboe J & Tybjaerg HA (1977): The Copenhagen City Heart Study. A prospective cardiovascular population study of 20 000 men and women. Ugeskr Laeger 139: 19211923.
  • Seddon JM, Ajani UA & Mitchell BD (1997): Familial aggregation of age-related maculopathy. Am J Ophthalmol 123: 199206.
  • Silvestri G, Johnston PB & Hughes AE (1994): Is genetic predisposition an important risk factor in age-related macular degeneration? Eye 8: 564568.
  • Smith W, Assink J, Klein R et al. (2001): Risk factors for age-related macular degeneration: pooled findings from three continents. Ophthalmology 108: 697704.
  • Smith W & Mitchell P (1996): Alcohol intake and age-related maculopathy. Am J Ophthalmol 122: 743745.
  • Smith W & Mitchell P (1998): Family history and age-related maculopathy: the Blue Mountains Eye Study. Aust N Z J Ophthalmol 26: 203206.
  • Smith W, Mitchell P, Leeder SR & Wang JJ (1998): Plasma fibrinogen levels, other cardiovascular risk factors and age-related maculopathy: the Blue Mountains Eye Study. Arch Ophthalmol 116: 583587.
  • Souied EH, Benlian P, Amouyel P et al. (1998): The ε4 allele of the apolipoprotein E gene as a potential protective factor for exudative age-related macular degeneration. Am J Ophthalmol 125: 353359.
  • Sparrow JM, Dickinson AJ, Duke AM et al. (1997): Seven-year follow-up of age-related maculopathy in an elderly British population. Eye 11: 315324.
  • Sperduto RD, Hiller R & Seigel D (1981): Lens opacities and senile maculopathy. Arch Ophthalmol 99: 10041008.
  • Taylor HR, McCarty CA & Nanjan MB (2000): Vision impairment predicts 5-year mortality. Trans Am Ophthalmol Soc 98: 9199.
  • Tomany SC, Wang JJ, Van Leeuwen R et al. (2004): Risk factors for incident age-related macular degeneration. Pooled findings from three continents. Ophthalmology 111: 12801287.
  • Tuo J, Bojanowski CM & Chan CC (2004): Genetic factors of age-related macular degeneration. Prog Retin Eye Res 23: 229249.
  • Vinding T (1995): Age-related macular degeneration. An epidemiological study of 1000 elderly individuals with reference to prevalence, funduscopic findings, visual impairment and risk factors. Acta Ophthalmol Scand 218 (73): 132.
  • Vinding T, Appleyard M, Nyboe J & Jensen G (1992): Risk factor analysis for atrophic and exudative age-related macular degeneration. An epidemiological study of 1000 aged individuals. Acta Ophthalmol (Copenh) 70: 6672.
  • Wang JJ, Klein R, Smith W et al. (2003): Cataract surgery and the 5-year incidence of late-stage age-related maculopathy: pooled findings from the Beaver Dam and Blue Mountains Eye Studies. Ophthalmology 110: 19601967.
  • Wang JJ, Mitchell P, Simpson JM et al. (2001): Visual impairment, age-related cataract and mortality. Arch Ophthalmol 119: 11861190.
  • West SK, Rosenthal FS, Bressler NM et al. (1989): Exposure to sunlight and other risk factors for age-related macular degeneration. Arch Ophthalmol 107: 875879.
  • Zareparsi S, Reddick AC, Branham KE et al. (2004): Association of apolipoprotein E alleles with susceptibility to age-related macular degeneration in a large cohort from a single centre. Invest Ophthalmol Vis Sci 45: 13061310.